Ballew Advisors’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Ballew Advisors’s Portfolio KERX Stock Details KERX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-28	Closed	–	–	512
2018 Q3	$0	Buy	+28	New	+$101	﹤0.01%	531

Ballew Advisors's KERX Position: Q4 2018 in Review

Ballew Advisors sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 28 shares.

Ballew Advisors first reported a position in KERX in Q3 2018 and held it in 1 quarter. The position peaked at $0 in Q3 2018. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.

Ballew Advisors reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
Ballew Advisors sold 28 Keryx Biopharmaceuticals Inc shares in Q4 2018.
Ballew Advisors first reported a position in Keryx Biopharmaceuticals Inc in Q3 2018 and held it in 1 quarter.
Ballew Advisors's Keryx Biopharmaceuticals Inc position peaked at $0 in Q3 2018.
1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.

Based on Ballew Advisors's 13F filing for Q4 2018, filed 12 Feb 2019.